ID   ABEC1_RAT               Reviewed;         229 AA.
AC   P38483;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1994, sequence version 1.
DT   02-OCT-2024, entry version 166.
DE   RecName: Full=C->U-editing enzyme APOBEC-1 {ECO:0000305|PubMed:8511591};
DE            EC=3.5.4.- {ECO:0000269|PubMed:8511591};
DE   AltName: Full=Apo B messenger RNA-editing protein {ECO:0000303|PubMed:8511591};
DE            Short=REPR {ECO:0000303|PubMed:8511591};
DE   AltName: Full=Apolipoprotein B mRNA-editing enzyme catalytic subunit 1 {ECO:0000312|RGD:2133};
DE            Short=APOBEC-1 {ECO:0000303|PubMed:10669759};
DE            Short=Apolipoprotein B mRNA-editing enzyme 1;
DE            EC=3.5.4.36 {ECO:0000269|PubMed:8511591};
DE   AltName: Full=mRNA(cytosine(6666)) deaminase 1 {ECO:0000305|PubMed:8511591};
GN   Name=Apobec1 {ECO:0000312|RGD:2133};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND CATALYTIC ACTIVITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Small intestine;
RX   PubMed=8511591; DOI=10.1126/science.8511591;
RA   Teng B., Burant C.F., Davidson N.O.;
RT   "Molecular cloning of an apolipoprotein B messenger RNA editing protein.";
RL   Science 260:1816-1819(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   INTERACTION WITH A1CF.
RX   PubMed=10669759; DOI=10.1128/mcb.20.5.1846-1854.2000;
RA   Mehta A., Kinter M.T., Sherman N.E., Driscoll D.M.;
RT   "Molecular cloning of APOBEC-1 complementation factor, a novel RNA-binding
RT   protein involved in the editing of apolipoprotein B mRNA.";
RL   Mol. Cell. Biol. 20:1846-1854(2000).
RN   [4]
RP   INTERACTION WITH SYNCRIP.
RX   PubMed=11134005; DOI=10.1074/jbc.m006435200;
RA   Blanc V., Navaratnam N., Henderson J.O., Anant S., Kennedy S., Jarmuz A.,
RA   Scott J., Davidson N.O.;
RT   "Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that
RT   interacts with both apobec-1 and apobec-1 complementation factor to
RT   modulate C to U editing.";
RL   J. Biol. Chem. 276:10272-10283(2001).
CC   -!- FUNCTION: Cytidine deaminase catalyzing the cytidine to uridine
CC       postranscriptional editing of a variety of mRNAs. Form complexes with
CC       cofactors that confer differential editing activity and selectivity.
CC       Responsible for the postranscriptional editing of a CAA codon for Gln
CC       to a UAA codon for stop in the apolipoprotein B mRNA (PubMed:8511591).
CC       Also involved in CGA (Arg) to UGA (Stop) editing in the NF1 mRNA (By
CC       similarity). May also play a role in the epigenetic regulation of gene
CC       expression by participating in DNA demethylation (By similarity).
CC       {ECO:0000250|UniProtKB:P41238, ECO:0000250|UniProtKB:P51908,
CC       ECO:0000269|PubMed:8511591}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a cytidine in mRNA + H(+) + H2O = a uridine in mRNA + NH4(+);
CC         Xref=Rhea:RHEA:74355, Rhea:RHEA-COMP:14658, Rhea:RHEA-COMP:15145,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:65315, ChEBI:CHEBI:82748;
CC         Evidence={ECO:0000250|UniProtKB:P41238};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:74356;
CC         Evidence={ECO:0000250|UniProtKB:P41238};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=cytidine(6666) in apoB mRNA + H(+) + H2O = NH4(+) +
CC         uridine(6666) in apoB mRNA; Xref=Rhea:RHEA:21772, Rhea:RHEA-
CC         COMP:13888, Rhea:RHEA-COMP:13889, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:28938, ChEBI:CHEBI:65315,
CC         ChEBI:CHEBI:82748; EC=3.5.4.36;
CC         Evidence={ECO:0000269|PubMed:8511591};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21773;
CC         Evidence={ECO:0000269|PubMed:8511591};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:Q9Y235};
CC       Note=Binds 1 Zn(2+) ion per subunit. {ECO:0000250|UniProtKB:Q9Y235};
CC   -!- SUBUNIT: Homodimer (By similarity). Interacts with A1CF; form an mRNA
CC       editing complex (PubMed:10669759). Interacts with RBM47; form an mRNA
CC       editing complex (By similarity). Found in a complex with CELF2/CUGBP2
CC       and A1CF (By similarity). Interacts with HNRPAB (By similarity).
CC       Interacts with SYNCRIP (PubMed:11134005).
CC       {ECO:0000250|UniProtKB:P41238, ECO:0000269|PubMed:10669759,
CC       ECO:0000269|PubMed:11134005}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P41238}. Nucleus
CC       {ECO:0000250|UniProtKB:P41238}.
CC   -!- TISSUE SPECIFICITY: Expressed in the liver as well as small intestine.
CC   -!- SIMILARITY: Belongs to the cytidine and deoxycytidylate deaminase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L07114; AAA17394.1; -; mRNA.
DR   EMBL; BC085335; AAH85335.1; -; mRNA.
DR   PIR; I59577; I59577.
DR   RefSeq; NP_037039.1; NM_012907.2.
DR   RefSeq; XP_006237352.1; XM_006237290.2.
DR   RefSeq; XP_006237353.1; XM_006237291.2.
DR   RefSeq; XP_006237354.1; XM_006237292.2.
DR   RefSeq; XP_006237355.1; XM_006237293.2.
DR   RefSeq; XP_017447973.1; XM_017592484.1.
DR   AlphaFoldDB; P38483; -.
DR   SMR; P38483; -.
DR   CORUM; P38483; -.
DR   STRING; 10116.ENSRNOP00000020735; -.
DR   PhosphoSitePlus; P38483; -.
DR   PaxDb; 10116-ENSRNOP00000020735; -.
DR   GeneID; 25383; -.
DR   KEGG; rno:25383; -.
DR   UCSC; RGD:2133; rat.
DR   AGR; RGD:2133; -.
DR   CTD; 339; -.
DR   RGD; 2133; Apobec1.
DR   VEuPathDB; HostDB:ENSRNOG00000015411; -.
DR   eggNOG; ENOG502SNW2; Eukaryota.
DR   HOGENOM; CLU_080056_3_0_1; -.
DR   InParanoid; P38483; -.
DR   OrthoDB; 5296257at2759; -.
DR   PhylomeDB; P38483; -.
DR   TreeFam; TF331356; -.
DR   BRENDA; 3.5.4.36; 5301.
DR   Reactome; R-RNO-72200; mRNA Editing: C to U Conversion.
DR   Reactome; R-RNO-75094; Formation of the Editosome.
DR   PRO; PR:P38483; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000015411; Expressed in duodenum and 17 other cell types or tissues.
DR   GO; GO:0030895; C:apolipoprotein B mRNA editing enzyme complex; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0004126; F:cytidine deaminase activity; IDA:MGI.
DR   GO; GO:0004131; F:cytosine deaminase activity; IDA:RGD.
DR   GO; GO:0008047; F:enzyme activator activity; IDA:RGD.
DR   GO; GO:0035925; F:mRNA 3'-UTR AU-rich region binding; ISO:RGD.
DR   GO; GO:0003729; F:mRNA binding; IDA:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0043021; F:ribonucleoprotein complex binding; IPI:RGD.
DR   GO; GO:0003723; F:RNA binding; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IEP:RGD.
DR   GO; GO:0046087; P:cytidine metabolic process; IC:UniProtKB.
DR   GO; GO:0016554; P:cytidine to uridine editing; IDA:RGD.
DR   GO; GO:0051607; P:defense response to virus; IDA:RGD.
DR   GO; GO:0070383; P:DNA cytosine deamination; IDA:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0042158; P:lipoprotein biosynthetic process; ISO:RGD.
DR   GO; GO:0042157; P:lipoprotein metabolic process; ISO:RGD.
DR   GO; GO:0042953; P:lipoprotein transport; ISO:RGD.
DR   GO; GO:0016556; P:mRNA modification; IDA:RGD.
DR   GO; GO:0006397; P:mRNA processing; IEA:UniProtKB-KW.
DR   GO; GO:0048255; P:mRNA stabilization; ISO:RGD.
DR   GO; GO:2000623; P:negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; ISO:RGD.
DR   GO; GO:0090209; P:negative regulation of triglyceride metabolic process; ISO:RGD.
DR   GO; GO:0044029; P:positive regulation of gene expression via chromosomal CpG island demethylation; ISS:UniProtKB.
DR   GO; GO:0090366; P:positive regulation of mRNA modification; IDA:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0051592; P:response to calcium ion; IDA:RGD.
DR   GO; GO:0045471; P:response to ethanol; IDA:RGD.
DR   GO; GO:0010332; P:response to gamma radiation; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IDA:RGD.
DR   GO; GO:0010043; P:response to zinc ion; IEP:RGD.
DR   GO; GO:0006641; P:triglyceride metabolic process; ISO:RGD.
DR   CDD; cd01283; cytidine_deaminase; 1.
DR   Gene3D; 3.40.140.10; Cytidine Deaminase, domain 2; 1.
DR   InterPro; IPR016192; APOBEC/CMP_deaminase_Zn-bd.
DR   InterPro; IPR041547; APOBEC1.
DR   InterPro; IPR050610; APOBEC_Cyt_Deaminase.
DR   InterPro; IPR002125; CMP_dCMP_dom.
DR   InterPro; IPR016193; Cytidine_deaminase-like.
DR   PANTHER; PTHR13857:SF26; C-U-EDITING ENZYME APOBEC-1; 1.
DR   PANTHER; PTHR13857; MRNA EDITING ENZYME; 1.
DR   Pfam; PF18774; APOBEC4_like; 1.
DR   SUPFAM; SSF53927; Cytidine deaminase-like; 1.
DR   PROSITE; PS00903; CYT_DCMP_DEAMINASES_1; 1.
DR   PROSITE; PS51747; CYT_DCMP_DEAMINASES_2; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Hydrolase; Metal-binding; mRNA processing; Nucleus;
KW   Reference proteome; Zinc.
FT   CHAIN           1..229
FT                   /note="C->U-editing enzyme APOBEC-1"
FT                   /id="PRO_0000171748"
FT   DOMAIN          10..134
FT                   /note="CMP/dCMP-type deaminase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01083"
FT   ACT_SITE        63
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y235"
FT   BINDING         61
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y235"
FT   BINDING         93
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y235"
FT   BINDING         96
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Y235"
SQ   SEQUENCE   229 AA;  27274 MW;  08766441882789B3 CRC64;
     MSSETGPVAV DPTLRRRIEP HEFEVFFDPR ELRKETCLLY EINWGGRHSI WRHTSQNTNK
     HVEVNFIEKF TTERYFCPNT RCSITWFLSW SPCGECSRAI TEFLSRYPHV TLFIYIARLY
     HHADPRNRQG LRDLISSGVT IQIMTEQESG YCWRNFVNYS PSNEAHWPRY PHLWVRLYVL
     ELYCIILGLP PCLNILRRKQ PQLTFFTIAL QSCHYQRLPP HILWATGLK
//
